ICD-10-CM 2027 diagnosis code
C50.92Malignant neoplasm of breast of unspecified site, male
C50.92 is a header code, so it can't be reported by itself. Choose one of the 3 more specific codes beneath it.
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About C50.92
C50.92 is the ICD-10-CM diagnosis code for malignant neoplasm of breast of unspecified site, male. It belongs to category C50 (malignant neoplasm of breast), block C50 (malignant neoplasms of breast) and chapter 2 (neoplasms). It is a header code, so it can't be reported by itself; one of its 3 subcodes must be used instead.
Within C50.9 (malignant neoplasm of breast of unspecified site), C50.92 is specifically for malignant neoplasm of breast of unspecified site, male. Related codes cover female (C50.91).
To report this condition, pick the subcode that matches the documentation: C50.921 (breast), C50.922 (breast) and C50.929 (breast).
Use an additional code to identify estrogen, and other hormones and factors receptor status (Z17.-).
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Specific codes under C50.92
Notes that apply from higher levels
Instructions written at a parent level also apply to C50.92.
Broader instructions also apply from Chapter 2: Neoplasms.
Alphabetic index entries
25 entriesTerms in the official ICD-10-CM index that lead to C50.92.
- Adenocarcinoma › duct › infiltrating › unspecified site (female) › male
- Adenocarcinoma › infiltrating duct › unspecified site (female) › male
- Adenocarcinoma › inflammatory › unspecified site (female) › male
- Adenocarcinoma › intraductal › noninfiltrating › papillary › with invasion › unspecified site (female) › male
- Adenocarcinoma › intraductal › papillary › with invasion › unspecified site (female) › male
- Adenocarcinoma › lobular › unspecified site (female) › male
- Adenocarcinoma › papillary › intraductal (noninfiltrating) › with invasion › unspecified site (female) › male
- Carcinoma (malignant) › duct (cell) › infiltrating › with lobular carcinoma (in situ) › unspecified site (female) › male
- Carcinoma (malignant) › duct (cell) › infiltrating › specified site › unspecified site (female) › male
- Carcinoma (malignant) › ductal › with lobular › unspecified site (female) › male
- Carcinoma (malignant) › ductular, infiltrating › unspecified site (female) › male
- Carcinoma (malignant) › infiltrating › duct › with lobular › unspecified site (female) › male
- Carcinoma (malignant) › infiltrating › duct › unspecified site (female) › male
- Carcinoma (malignant) › infiltrating › ductular › unspecified site (female) › male
- Carcinoma (malignant) › infiltrating › lobular › unspecified site (female) › male
- Carcinoma (malignant) › inflammatory › unspecified site (female) › male
- Carcinoma (malignant) › intraductal (noninfiltrating) › papillary › with invasion › unspecified site (female) › male
- Carcinoma (malignant) › lipid-rich (female) › male
- Carcinoma (malignant) › lobular (infiltrating) › with intraductal › unspecified site (female) › male
- Carcinoma (malignant) › lobular (infiltrating) › unspecified site (female) › male
- Carcinoma (malignant) › medullary › with › lymphoid stroma › unspecified site (female) › male
- Carcinoma (malignant) › papillary › intraductal (noninfiltrating) › with invasion › unspecified site (female) › male
- Carcinoma-in-situ › lobular › with › infiltrating duct › breast (female) › male
- Carcinoma-in-situ › lobular › with › infiltrating duct › unspecified site (female) › male
- Disease, diseased › breast › Paget's › male, unspecified side
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about C50.92
Is C50.92 billable?
- No. C50.92 is a header code. Report one of its more specific subcodes instead.